US20190314084A1 - Cavitary tissue ablation - Google Patents

Abstract

The invention relates to a tissue ablation system including an ablation device having a deployable applicator head configured to be delivered to a tissue cavity and ablate marginal tissue surrounding the tissue cavity. The deployable applicator head is configured to be delivered to a tissue cavity while in a collapsed configuration and ablate marginal tissue surrounding the tissue cavity while in an expanded configuration.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS
• This application is a continuation of U.S. Non-Provisional application Ser. No. 15/142,616, filed Apr. 29, 2016, which claims the benefit of, and priority to, U.S. Provisional Application Ser. No. 62/154,377, filed Apr. 29, 2015, the contents of which are hereby incorporated by reference herein in their entirety.
FIELD
• The present disclosure relates generally to medical devices, and, more particularly, to a tissue ablation device having a deployable applicator head configured to be delivered to a tissue cavity and ablate marginal tissue surrounding the tissue cavity.
BACKGROUND
• Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. Cancer generally manifests into abnormal growths of tissue in the form of a tumor that may be localized to a particular area of a patient's body (e.g., associated with a specific body part or organ) or may be spread throughout. Tumors, both benign and malignant, are commonly treated and removed via surgical intervention, as surgery often offers the greatest chance for complete removal and cure, especially if the cancer has not spread to other parts of the body. However, in some instances, surgery alone is insufficient to adequately remove all cancerous tissue from a local environment.
• For example, treatment of early stage breast cancer typically involves a combination of surgery and adjuvant irradiation. Unlike a mastectomy, a lumpectomy removes only the tumor and a small rim (area) of the normal tissue around it. Radiation therapy is given after lumpectomy in an attempt to eradicate cancer cells that may remain in the local environment around the removed tumor, so as to lower the chances of the cancer returning. However, radiation therapy as a post-operative treatment suffers various shortcomings. For example, radiation techniques can be costly and time consuming, and typically involve multiple treatments over weeks and sometimes months. Furthermore, radiation often results in unintended damage to the tissue outside the target zone. Thus, rather than affecting the likely residual tissue, typically near the original tumor location, radiation techniques often adversely affect healthy tissue, such as short and long-term complications affecting the skin, lungs, and heart. Accordingly, such risks, when combined with the burden of weeks of daily radiation, may drive some patients to choose mastectomy instead of lumpectomy. Furthermore, some women (e.g., up to thirty percent (30%)) who undergo lumpectomy stop therapy before completing the full treatment due to the drawbacks of radiation treatment. This may be especially true in rural areas, or other areas in which patients may have limited access to radiation facilities.
SUMMARY
• Tumors, both benign and malignant, are commonly treated and destroyed via surgical intervention, as surgery often offers the greatest chance for complete removal and cure, especially if the cancer has not metastasized. However, after the tumor is destroyed, a hollow cavity may remain, wherein tissue surrounding this cavity and surrounding the original tumor site can still leave abnormal or potentially cancerous cells that the surgeon fails, or is unable, to excise. This surrounding tissue is commonly referred to as “margin tissue” or “marginal tissue”, and is the location within a patient where a reoccurrence of the tumor may most likely occur.
• The tissue ablation system of the present disclosure can be used during an ablation procedure to destroy the thin rim of marginal tissue around the cavity in an effort to manage residual disease in the local environment that has been treated. In particular, the present disclosure is generally directed to a cavitary tissue ablation system including an ablation device to be delivered into a tissue cavity and emit non-ionizing radiation, such as radiofrequency (RF) energy, to treat the marginal tissue around the tissue cavity. The ablation device generally includes a probe having a deployable applicator member or head coupled thereto and configured to transition between a collapsed configuration, in which the applicator head can be delivered to and maneuvered within a previously formed tissue cavity (e.g., formed from tumor removal), and an expanded configuration, in which the applicator head is configured to ablate marginal tissue (via RF) immediately surrounding the site of a surgically removed tumor in order to minimize recurrence of the tumor. The tissue ablation device of the present disclosure is configured to allow surgeons, or other medical professionals, to deliver precise, measured doses of RF energy at controlled depths to the marginal tissue surrounding the cavity.
• Accordingly, a tissue ablation device consistent with the present disclosure may be well suited for treating hollow body cavities, such as irregularly-shaped cavities in breast tissue created by a lumpectomy procedure. It should be noted, however, that the devices of the present disclosure are not limited to such post-surgical treatments and, as used herein, the phrase “body cavity” may include non-surgically created cavities, such as natural body cavities and passages, such as the ureter (e.g. for prostate treatment), the uterus (e.g. for uterine ablation or fibroid treatment), fallopian tubes (e.g. for sterilization), and the like. Additionally, or alternatively, tissue ablation devices of the present disclosure may be used for the ablation of marginal tissue in various parts of the body and organs (e.g., skin, lungs, liver, pancreas, etc.) and is not limited to treatment of breast cancer.
• In one aspect, a tissue ablation device consistent with the present disclosure includes a dual-balloon design. For example, the tissue ablation device includes a probe including a nonconductive elongated shaft having a proximal end and a distal end and at least one lumen extending therethrough, and an expandable balloon assembly coupled to the distal end of the probe shaft. The expandable balloon assembly includes an expandable inner balloon having an inner balloon wall having an exterior surface, an interior surface and a lumen defined therein and in fluid connection with at least one lumen of the probe. The inner balloon is configured to inflate into an expanded configuration in response to delivery of a first fluid from at least one lumen of the probe into the lumen of the inner balloon.
• The expandable balloon assembly further includes an expandable outer balloon surrounding the inner balloon and configured to transition to an expanded configuration in response expansion of the inner balloon. The outer balloon includes an outer balloon wall having an interior surface, an exterior surface, and a chamber defined between the interior surface of the outer balloon and the exterior surface of the inner balloon. The exterior surface of the inner balloon wall has an irregular surface defined thereon. In particular, the inner balloon wall may include a plurality of bumps, ridges, or other features arranged on an outer surface thereof configured to maintain separation between the outer surface of the inner balloon wall and the interior surface of the outer balloon wall, thereby ensuring the chamber is maintained.
• The chamber defined between the inner surface of the outer balloon wall and the outer surface of the inner balloon wall is in fluid connection with at least one lumen of the probe, so as to receive a second fluid therefrom. The outer balloon wall further includes a plurality of perforations configured to allow the passage of the second fluid from the chamber to the exterior surface of the outer balloon upon delivery of the second fluid from at least one lumen of the probe into the chamber.
• The ablation device further includes an electrode array comprising a plurality of conductive wires positioned within the chamber between the exterior surface of the inner balloon wall and the interior surface of the outer balloon wall. Each of the plurality of conductive wires is configured to conduct energy to be carried by the second fluid within the chamber from the interior surface to the exterior surface of the outer balloon wall for ablation of a target tissue. In particular, upon activating delivery of RF energy from the at least one conductive element, the RF energy is transmitted from the conductive element to the exterior surface of the outer balloon by way of fluid weeping from the perforations, thereby creating a virtual electrode. For example, the fluid within the chamber and weeping through the perforations on the outer balloon is a conductive fluid (e.g., saline) and thus able to carry electrical current from an active conductive element. Upon the fluid weeping through the perforations, a pool or thin film of fluid is formed on the exterior surface of the outer balloon and is configured to ablate surrounding tissue via the electrical current carried from the active conductive elements. Accordingly, ablation via RF energy is able to occur on the exterior surface of the outer balloon in a controlled manner and does not require direct contact between tissue and the conductive elements.
• In some embodiments, each of the plurality of conductive wires is independent from one another. Thus, in some embodiments, each of the plurality of conductive wires, or one or more sets of a combination of conductive wires, is configured to independently receive an electrical current from an energy source and independently conduct energy. In some embodiments, each of the plurality of conductive wires is configured to conduct energy upon receipt of the electrical current, the energy including RF energy.
• In some embodiments, the irregular surface defined on the exterior surface of the inner balloon wall may include a plurality of ridges. The plurality of ridges may generally extend longitudinally along the exterior surface of the inner balloon wall. The plurality of ridges may be configured to make contact with the inner surface of the outer balloon wall to maintain separation between the remaining outer surface of the inner balloon wall and the inner surface of the outer balloon wall. Each of the plurality of conductive wires may further be positioned between two adjacent ridges and one or more of the plurality of perforations of the outer balloon wall may be substantially aligned with an associated one of the plurality of conductive wires.
• In some embodiments, the inner balloon may be configured to receive the first fluid from a first lumen of the probe and the outer balloon may be configured to receive the second fluid from a second lumen of the probe. The delivery of the first and second fluids to the inner and outer balloons, respectively, may be independently controllable via a controller, for example. In some embodiments, the first and second fluids are different. In other embodiments, the first and second fluids are the same. In some embodiments, at least the second fluid, which is to be delivered to the chamber and used for creating a virtual electrode in combination with the electrode array, is a conductive fluid, such as saline.
• The dual-balloon design is particularly advantageous in that it does not require a syringe pump, and can be supplied with gravity-fed fluid source. In addition, the volume of fluid required within the chamber is significantly less (when compared to a single balloon design), thus less wattage is required to achieve RF ablation.
• In another aspect, a tissue ablation device consistent with the present disclosure includes an expandable mesh body configured to deliver energy for tissue ablation. The tissue ablation device includes a probe comprising an elongated shaft having a proximal end and a distal end and at least one lumen providing a pathway extending from the proximal end to the distal end and an expandable mesh assembly coupled to the distal end of the probe. The mesh assembly includes a self-expanding mesh body configured to transition between a collapsed configuration and an expanded configuration. When in the collapsed configuration, the mesh body is received within the at least one lumen of the probe and when in the expanded configuration, the mesh body is deployed from the at least one lumen of the probe and expands into a predefined shape. The mesh body is comprised of an electrically conductive material and configured to conduct and deliver electrical current to target tissue when in the expanded configuration.
• In some embodiments, the self-expanding mesh body includes a webbing coating one or more portions of the mesh body, wherein the web comprises a non-conductive material. The webbing is configured to block delivery of electrical current from the one or more portions of mesh body coated with the webbing.
BRIEF DESCRIPTION OF THE DRAWINGS
• Features and advantages of the claimed subject matter will be apparent from the following detailed description of embodiments consistent therewith, which description should be considered with reference to the accompanying drawings, wherein:
• FIG. 1 is a schematic illustration of an ablation system consistent with the present disclosure.
• FIGS. 2A-2C are perspective views of an exemplary embodiment of a tissue ablation device including an expandable applicator head configured to transition between collapsed and expanded configurations and to ablate marginal tissue;
• FIG. 3 is a perspective view, partly in section, of one embodiment of an applicator head compatible with the tissue ablation device ofFIG. 1;
• FIG. 4 is a perspective view of another embodiment of an applicator head compatible with the tissue ablation device ofFIG. 1;
• FIG. 5 is an exploded view of the applicator head ofFIG. 4;
• FIG. is a perspective view, partly in section, of the applicator head ofFIG. 4;
• FIGS. 7A and 7B are sectional views of a portion of the applicator head ofFIG. 6 illustrating the arrangement of components relative to one another;
• FIG. 8 is a schematic illustration of the delivery of the applicator head ofFIG. 3 into a tissue cavity and subsequent ablation of marginal tissue according to methods of the present disclosure;
• FIG. 9 is a perspective view of another embodiment of an applicator head compatible with the tissue ablation device ofFIG. 1;
• FIG. 10 illustrates a method of deploying the applicator head ofFIG. 9 into an expanded configuration for delivery of RF energy to a target site for ablation of marginal tissue;
• FIG. 11 illustrates different embodiments of the outer surface of the applicator head ofFIG. 9; and
• FIG. 12 is a schematic illustration of the delivery of the applicator head ofFIG. 9 into a tissue cavity and subsequent ablation of marginal tissue according to methods of the present disclosure.
• For a thorough understanding of the present disclosure, reference should be made to the following detailed description, including the appended claims, in connection with the above-described drawings. Although the present disclosure is described in connection with exemplary embodiments, the disclosure is not intended to be limited to the specific forms set forth herein. It is understood that various omissions and substitutions of equivalents are contemplated as circumstances may suggest or render expedient.
DETAILED DESCRIPTION
• By way of overview, the present disclosure is generally directed to a tissue ablation device having a deployable applicator head configured to be delivered into a tissue cavity and ablate marginal tissue surrounding the tissue cavity.
• The tissue ablation system of the present disclosure can be used during an ablation procedure to destroy the thin rim of marginal tissue around the cavity in an effort to manage residual disease in the local environment that has been treated. In particular, the present disclosure is generally directed to a cavitary tissue ablation system including an ablation device to be delivered into a tissue cavity and emit non-ionizing radiation, such as radiofrequency (RF) energy, to treat the marginal tissue around the tissue cavity. The ablation device generally includes a probe having a deployable applicator head coupled thereto and configured to transition between a collapsed configuration, in which the applicator head can be delivered to and maneuvered within a previously formed tissue cavity (e.g., formed from tumor removal), and an expanded configuration, in which the applicator head is configured to ablate marginal tissue (via RF) immediately surrounding the site of a surgically removed tumor in order to minimize recurrence of the tumor. The tissue ablation device of the present disclosure is configured to allow surgeons, or other medical professionals, to deliver precise, measured doses of RF energy at controlled depths to the marginal tissue surrounding the cavity.
• Accordingly, a tissue ablation device consistent with the present disclosure may be well suited for treating hollow body cavities, such as irregularly-shaped cavities in breast tissue created by a lumpectomy procedure. It should be noted, however, that the devices of the present disclosure are not limited to such post-surgical treatments and, as used herein, the phrase “body cavity” may include non-surgically created cavities, such as natural body cavities and passages, such as the ureter (e.g. for prostate treatment), the uterus (e.g. for uterine ablation or fibroid treatment), fallopian tubes (e.g. for sterilization), and the like. Additionally, or alternatively, tissue ablation devices of the present disclosure may be used for the ablation of marginal tissue in various parts of the body and organs (e.g., skin, lungs, liver, pancreas, etc.) and is not limited to treatment of breast cancer.
• FIG. 1 is a schematic illustration of anablation system10 for providing ablation of marginal tissue during a tumor removal procedure in apatient12. Theablation system10 generally includes anablation device14, which includes a probe having a deployable applicator member orhead16 and anelongated catheter shaft17 to which thedeployable applicator head16 is connected. Thecatheter shaft17 may generally include a nonconductive elongated member including a fluid delivery lumen. Theablation device14 may further be coupled to adevice controller18 and anablation generator20 over an electrical connection, and an irrigation pump ordrip22 over a fluid connection. As will be described in greater detail herein, thedevice controller18 may be used to control the emission of energy from one or more conductive elements of thedevice14 to result in ablation, as well as controlling the delivery of fluid to or from thedeployable applicator head16 so as to control the expansion and collapse of thehead16. In some cases, thedevice controller18 may be housed within theablation device14. Theablation generator20 may also connected to areturn electrode15 that is attached to the skin of thepatient12.
• As will be described in greater detail herein, during an ablation treatment, theablation generator20 may generally provide RF energy (e.g., electrical energy in the radiofrequency (RF) range (e.g., 350-800 kHz)) to an electrode array of theablation device14, as controlled by thedevice controller18. At the same time, saline may also be released from thehead16. The RF energy travels through the blood and tissue of the patient12 to thereturn electrode15 and, in the process, ablates the region(s) of tissues adjacent to portions of the electrode array that have been activated.
• Turning toFIGS. 2A-2C, one embodiment of an exemplary tissue ablation device configured to ablate marginal tissue is shown. The tissue ablation devices of the present disclosure generally include a probe including ashaft17 having a proximal end and a distal end, wherein theapplicator head16 is positioned at the distal end. In some embodiments, theshaft17 of the probe may generally resemble a catheter and thus may further include at least one lumen for providing a pathway from the proximal end of the shaft to the distal end of the shaft and the applicator head so as to allow various components to be in fluid communication with the applicator head.
• For example, in one embodiment, the applicator head includes at least one balloon configured to transition from a collapsed configuration to an expanded configuration in response to delivery of a fluid thereto.FIGS. 2A-2C illustrate theapplicator head16 transitioning from a collapsed configuration (FIG. 2A) to an expanded configuration (FIG. 2B) via delivery of a fluid to thehead16 and activated to emit energy for ablation of tissue (FIG. 2C). The at least one lumen of theshaft17 may provide a fluid pathway from the proximal end, which may be coupled to a fluid source (i.e., irrigation pump or drip22), and the interior volume of theballoon16. Furthermore, as will be described in greater detail herein, the tissue ablation devices of the present disclosure further include a conductive element19 (e.g., an electrode) positioned within theapplicator head16 and configured to deliver RF energy for the ablation of marginal tissue. Accordingly, the probe may be coupled to anRF generator20, for example, by way of an electrical connection at the proximal end, and wiring may pass through the at least one lumen of theshaft17 to theconductive element19. Further, in another embodiment, the applicator head may include a self-expanding mesh-like conductive element configured to deliver RF energy upon delivery to the target site. Accordingly, one or more control wires or other components may be coupled to the mesh-like conductive element to control the retraction and expansion (e.g., via pushing and pulling) of the mesh-like conductive element from the shaft of the probe, as well as electrical wiring for electrically coupling the conductive element and RF generator, wherein such control and electrical wires may be housed within the at least one lumen of the shaft of the probe.
• Accordingly, in some embodiments, theshaft17 of the probe may be configured as a handle adapted for manual manipulation. It should be noted, however, that in other embodiments, the shaft may be configured for connection to and/or interface with a surgical robot, such as the Da Vinci® surgical robot available from Intuitive Surgical, Inc., Sunnyvale, Calif. In all cases, the shaft may be configured to be held in place by a shape lock or other deployment and suspension system of the type that is anchored to a patient bed and which holds the probe in place while the ablation or other procedure takes place, eliminating the need to a user to manually hold the device for the duration of the treatment.
• FIG. 3 is a perspective view, partly in section, of one embodiment of anapplicator head100 compatible with thetissue ablation device14 ofFIG. 1. As shown, theapplicator head100 includes aninflatable balloon102 having a plurality ofperforations104, holes, or micropores, so as to allow a fluid provided within theballoon102, such as saline, to pass therethrough, or weep, from theballoon102 when theballoon102 is inflated. Theperforations104 may be sized, shaped, and/or arranged in such a pattern so as to allow a volume of fluid to pass from the interior volume of the balloon to an exterior surface of the balloon at a controlled rate so as to allow the balloon to remain inflated and maintain its shape.
• As previously described, the probe further includes aconductive element106, such as an electrode, positioned within the balloon, wherein theelectrode106 is coupled to anRF energy source20. When in the collapsed configuration (e.g., little or no fluid within the interior volume) (shown inFIG. 2A), the balloon has a smaller size or volume than when the balloon is in the expanded configuration. Once positioned within the target site (e.g., tissue cavity), fluid may then be delivered to the balloon so as to inflate the balloon into an expanded configuration (shown inFIG. 2B), at which point, ablation of marginal tissue can occur. In particular, an operator (e.g., surgeon) may initiate delivery of RF energy from theconductive element106 by using thecontroller18, and RF energy is transmitted from theconductive element106 to the outer surface of theballoon102 by way of the fluid weeping from theperforations104. Accordingly, ablation via RF energy is able to occur on the exterior surface (shown inFIG. 2C). More specifically, upon activating delivery of RF energy from the conductive element (electrode), the RF energy is transmitted from the conductive element to the outer surface of the balloon by way of the fluid weeping from the perforations, thereby creating a virtual electrode. For example, the fluid within the interior of theballoon102 and weeping through theperforations104 to the outer surface of theballoon102 is a conductive fluid (e.g., saline) and thus able to carry electrical current from theactive electrode106. Accordingly, upon the fluid weeping through theperforations104, a pool or thin film of fluid is formed on the exterior surface of theballoon102 and is configured to ablate surrounding tissue via the electrical current carried from theactive electrode106. Accordingly, ablation via RF energy is able to occur on the exterior surface of the balloon in a controlled manner and does not require direct contact between tissue and theelectrode106.
• FIG. 4 is a perspective view of another embodiment of anapplicator head200 compatible with thetissue ablation device14 andFIG. 5 is an exploded view of theapplicator head200 ofFIG. 4. As shown, theapplicator head200 includes a multiple-balloon design. For example, theapplicator head200 includes aninner balloon202 coupled to a first fluid source via afirst fluid line24aand configured to inflate into an expanded configuration in response to the delivery of fluid (e.g., saline) thereto. Theapplicator head200 further includes anouter balloon204 surrounding theinner balloon202 and configured to correspondingly expand or collapse in response to expansion or collapse of theinner balloon202.
• Theinner balloon202 may include an irregularouter surface208, which may include a plurality of bumps, ridges, or other features, configured to maintain separation between the outer surface of theinner balloon202 and an interior surface of theouter balloon204, thereby ensuring that a chamber is maintained between the inner and outer balloons. Theouter balloon204 may be coupled to a second fluid source (or the first fluid source) via asecond fluid line24b. Theouter balloon204 may further include a plurality of perforations or holes210 so as to allow fluid from the second fluid source to pass therethrough, or weep, from theouter balloon204. The perforations may be sized, shaped, and/or arranged in such a pattern so as to allow a volume of fluid to pass from the chamber to an exterior surface of the outer balloon at a controlled rate.
• Theapplicator head200 further includes one or more conductive elements, generally resembling electrically conductive wires ortines206, positioned within the chamber area between theinner balloon202 andouter balloon204. Theconductive elements206 are coupled to theRF generator20 via anelectrical line26, and configured to conduct electrical current to be carried by the fluid within the chamber from the interior surface to the exterior surface of theouter balloon204 for ablation of a target tissue, as will be described in greater detail herein. It should be noted that in one embodiment, the plurality ofconductive wires206 may be electrically isolated and independent from one another. This design allows for each conductive wire to receive energy in the form of electrical current from a source (e.g., RF generator) and emit RF energy in response. The system may include adevice controller18, for example, configured to selectively control the supply of electrical current to each of theconductive wires206.
• FIG. 6 is a perspective view, partly in section, of theapplicator head200 illustrating compatible with the tissue ablation device ofFIG. 1.FIGS. 7A and 7B are sectional views of a portion of theapplicator head200 illustrating the arrangement of components relative to one another.
• As shown inFIG. 6, the inner and outer balloons include achamber214 defined there between. In particular, the plurality of bumps orridges208 arranged on an outer surface of theinner balloon202 are configured to maintain separation between the outer surface of theinner balloon202 and an interior surface of theouter balloon204, thereby ensuring thechamber214 is maintained.
• Once positioned within the target site, a first fluid may be delivered to alumen212 of theinner balloon202, so as to inflate theinner balloon202 into an expanded configuration, at which point, theouter balloon204 further expands. A second fluid may then be delivered to theouter balloon204 such that the second fluid flows within thechamber214 between the inner andouter balloons202,204 and weeps from theouter balloon204 via theperforations210. Upon activating delivery of RF energy from theconductive elements206, the RF energy is transmitted from theconductive elements206 to the outer surface of theouter balloon204 by way of the fluid weeping from theperforations210, thereby creating a virtual electrode. For example, the fluid within thechamber214 and weeping through theperforations210 on theouter balloon204 is a conductive fluid (e.g., saline) and thus able to carry electrical current from the activeconductive elements206. Accordingly, upon the fluid weeping through theperforations210, a pool or thin film of fluid is formed on the exterior surface of theouter balloon204 and is configured to ablate surrounding tissue via the electrical current carried from the activeconductive elements206. Accordingly, ablation via RF energy is able to occur on the exterior surface of theouter balloon204 in a controlled manner and does not require direct contact between tissue and theconductive elements206.
• This embodiment is particularly advantageous in that the dual-balloon design does not require a syringe pump, and can be supplied with gravity-fedfluid source22. In addition, the volume of fluid required within the chamber is significantly less (when compared to a single balloon design), thus less wattage is required to achieve RF ablation. Another advantage of the dual-balloon design ofapplicator head200 is that it is not limited to placement within tissue cavities. Rather, when in a collapsed state, theapplicator head200 is shaped and/or sized to fit through working channels of scopes or other access devices, for example, and thus be used for ablation in a plurality of locations within the human body.
• It should be further noted that thedevice14 of the present disclosure, including theapplicator head200, may further be equipped with feedback capabilities. For example, while in a deflated, collapsed configuration, and prior to saline flow, thehead200 may be used for the collection of initial data (e.g., temperature and conductivity measurements (impedance measurements) from one or more of theconductive elements206. Then, upon carrying out the ablation procedure, after certain time ablating, saline flow may be stopped (controlled via controller18), and subsequent impedance measurements may be taken. The collection of data prior and during an ablation procedure may be processed by thecontroller18 so as to provide an estimation of the state of the tissue during an RF ablation procedure, thereby providing an operator (e.g., surgeon) with an accurate indication success of the procedure.
• FIG. 8 is a schematic illustration of the delivery of theapplicator head100 ofFIG. 3 into a tissue cavity and subsequent ablation of marginal tissue according to methods of the present disclosure.
• FIG. 9 is a perspective view of another embodiment of an applicator head compatible with the tissue ablation device ofFIG. 1.FIG. 10 illustrates a method of deploying the applicator head ofFIG. 9 into an expanded configuration for delivery of RF energy to a target site for ablation of marginal tissue.FIG. 11 illustrates different embodiments of the outer surface of the applicator head ofFIG. 9.
• As shown, the applicator head may include a silicone-webbed mesh body composed of an electrically conductive material. The mesh body may be self-expanding such that it is able to transition from a collapsed configuration, in which the mesh body is retracted within a portion of the shaft of the probe, to an expanded configuration upon deployment from the shaft of the probe. Accordingly, the mesh body may include a shape-memory alloy, or similar material, so as to allow the mesh body to transition between collapsed and expanded configurations. The mesh body is further composed of an electrically conductive material and coupled to an RF generator, such that the mesh body is configured to deliver RF energy. The mesh body may include webbing material that is applied via a dipping method, for example, such that certain portions of the coated mesh body can be exposed with a solvent, thereby enabling RF energy to be delivered through the mesh to a tissue surface when the mesh body is in the expanded configuration and in direct contact with tissue. In some embodiments, to enhance the ablation, perforations along the webbing may further allow fluid to be delivered to the outer surface of the mesh body. Since the mesh body is able to naturally expand, a fluid (e.g., saline) can be delivered via a gravity-fed bag, and no pump is needed. In some embodiments, an inner balloon may be included within the mesh body so as to reduce the volume of energized saline.
• FIG. 12 is a schematic illustration of the delivery of the applicator head ofFIG. 9 into a tissue cavity and subsequent ablation of marginal tissue according to methods of the present disclosure.
• Accordingly, a tissue ablation devices, particularly the applicator heads described herein, may be well suited for treating hollow body cavities, such as irregularly-shaped cavities in breast tissue created by a lumpectomy procedure. The devices, systems, and methods of the present disclosure can help to ensure that all microscopic disease in the local environment has been treated. This is especially true in the treatment of tumors that have a tendency to recur.
• As used in any embodiment herein, the term “controller”, “module”, “subsystem”, or the like, may refer to software, firmware and/or circuitry configured to perform any of the aforementioned operations. Software may be embodied as a software package, code, instructions, instruction sets and/or data recorded on non-transitory computer readable storage medium. Firmware may be embodied as code, instructions or instruction sets and/or data that are hard-coded (e.g., nonvolatile) in memory devices. “Circuitry”, as used in any embodiment herein, may comprise, for example, singly or in any combination, hardwired circuitry, programmable circuitry such as computer processors comprising one or more individual instruction processing cores, state machine circuitry, and/or firmware that stores instructions executed by programmable circuitry. The controller or subsystem may, collectively or individually, be embodied as circuitry that forms part of a larger system, for example, an integrated circuit (IC), system on-chip (SoC), desktop computers, laptop computers, tablet computers, servers, smart phones, etc.
• Any of the operations described herein may be implemented in a system that includes one or more storage mediums having stored thereon, individually or in combination, instructions that when executed by one or more processors perform the methods. Here, the processor may include, for example, a server CPU, a mobile device CPU, and/or other programmable circuitry.
• Also, it is intended that operations described herein may be distributed across a plurality of physical devices, such as processing structures at more than one different physical location. The storage medium may include any type of tangible medium, for example, any type of disk including hard disks, floppy disks, optical disks, compact disk read-only memories (CD-ROMs), compact disk rewritables (CD-RWs), and magneto-optical disks, semiconductor devices such as read-only memories (ROMs), random access memories (RAMs) such as dynamic and static RAMs, erasable programmable read-only memories (EPROMs), electrically erasable programmable read-only memories (EEPROMs), flash memories, Solid State Disks (SSDs), magnetic or optical cards, or any type of media suitable for storing electronic instructions. Other embodiments may be implemented as software modules executed by a programmable control device. The storage medium may be non-transitory.
• As described herein, various embodiments may be implemented using hardware elements, software elements, or any combination thereof. Examples of hardware elements may include processors, microprocessors, circuits, circuit elements (e.g., transistors, resistors, capacitors, inductors, and so forth), integrated circuits, application specific integrated circuits (ASIC), programmable logic devices (PLD), digital signal processors (DSP), field programmable gate array (FPGA), logic gates, registers, semiconductor device, chips, microchips, chip sets, and so forth.
• Reference throughout this specification to “one embodiment” or “an embodiment” means that a particular feature, structure, or characteristic described in connection with the embodiment is included in at least one embodiment. Thus, appearances of the phrases “in one embodiment” or “in an embodiment” in various places throughout this specification are not necessarily all referring to the same embodiment. Furthermore, the particular features, structures, or characteristics may be combined in any suitable manner in one or more embodiments.
• The terms and expressions which have been employed herein are used as terms of description and not of limitation, and there is no intention, in the use of such terms and expressions, of excluding any equivalents of the features shown and described (or portions thereof), and it is recognized that various modifications are possible within the scope of the claims. Accordingly, the claims are intended to cover all such equivalents.

Claims (20)

What is claimed is:

1. A medical device comprising:

a deployable applicator head comprising an expandable outer balloon having a plurality of perforations and an expandable inner balloon configured to maintain separation between an exterior surface of the inner balloon and an interior surface of the outer balloon thereby forming an interior chamber; and

a plurality of conductive wires disposed within the interior chamber and configured to conduct energy to be carried by a conductive fluid passing through one or more of the plurality of perforations, each of the plurality of conductive wires having a substantially constant cross-section along its length.

2. The medical device ofclaim 1, further comprising a nonconductive handle and a lumen extending therethrough that is in fluid connection with the interior chamber.

3. The medical device ofclaim 1, wherein the inner balloon is configured to transition from a collapsed configuration to an expanded configuration in response to delivery of a fluid thereto and the outer balloon is configured to correspondingly transition from a collapsed configuration to an expanded configuration in response to expansion of the inner balloon.

4. The medical device ofclaim 1, wherein, when in an expanded configuration, one or more of the plurality of perforations is configured to allow passage of the conductive fluid from the interior chamber to an exterior surface of the outer balloon.

5. The medical device ofclaim 4, wherein upon receipt of an electric current, each of the plurality of conductive wires is configured to conduct the energy to be carried by the conductive fluid passing through one or more of the plurality of perforations for ablation of a tissue.

6. The medical device ofclaim 5, wherein the interior chamber is a plurality of interior chambers.

7. The medical device ofclaim 6, wherein each of the plurality of conductive wires is disposed within a separate one of the plurality of interior chambers.

8. The medical device ofclaim 7, wherein each of the plurality of conductive wires extends from a proximal end of the separate one of the plurality of interior chambers to a distal end of the separate one of the plurality of interior chambers.

9. The medical device ofclaim 7, wherein each of the plurality of conductive wires, or one or more sets of a combination of conductive elements, is configured to independently receive an electrical current from an energy source and independently conduct energy.

10. The medical device ofclaim 9, wherein each of the plurality of conductive elements is substantially aligned with one of the plurality of perforations.

11. The medical device ofclaim 6, wherein the inner balloon comprises an irregular exterior surface comprising a plurality of ridges or protrusions oriented along a longitudinal axis of the inner balloon.

12. The medical device ofclaim 11, wherein the irregular exterior surface comprises the plurality of ridges, each pair of adjacent ridges of the plurality of ridges is configured to define each of the plurality of interior chambers.

13. The medical device ofclaim 2, wherein the lumen is a first lumen and second lumen and the inner balloon is configured to receive a first fluid from the first lumen and the outer balloon is configured to receive a second fluid from the second lumen.

14. The medical device ofclaim 13, wherein at least the second fluid is the conductive fluid.

15. The medical device ofclaim 13, further comprising a controller configured to independently control delivery of the first fluid and the second fluid to the inner balloon and to the outer balloon, respectively.

16. A medical device comprising:

a deployable applicator head comprising a self-expandable mesh body;

an electrical element configured to deliver an electric current to the self-expandable mesh body when in an expanded configuration; and

a nonconductive handle having a lumen extending therethrough that is in connection with the self-expanding mesh body.

17. The medical device ofclaim 16, wherein the lumen is configured to deploy the self-expandable mesh body into a predefined shape in the expanded configuration and to receive the self-expandable mesh body therein in a collapsed configuration.

18. The medical device ofclaim 17, wherein the self-expandable mesh body is comprised of an electrically conductive material and upon receipt of the electric current, is configured to conduct and deliver the electrical current to target tissue.

19. The medical device ofclaim 18, wherein the self-expandable mesh body comprises a nonconductive webbed coating covering one or more portions of the self-expandable mesh body.

20. The medical device ofclaim 19, wherein the nonconductive webbed coating comprises a plurality of perforations configured to allow passage of a fluid to an outer surface of the self-expandable mesh body when in the expanded configuration.

Images